{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T02:59:54Z","timestamp":1774234794469,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission (UGC)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.pharep.2018.02.016","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T19:02:53Z","timestamp":1529607773000},"page":"769-776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["S-allyl cysteine ameliorates cyclophosphamide-induced downregulation of urothelial uroplakin IIIa with a concomitant effect on expression and release of CCL11and TNF-\u03b1 in mice"],"prefix":"10.1007","volume":"70","author":[{"given":"Sayed Aliul Hasan","family":"Abdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd Amir","family":"Afjal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abul Kalam","family":"Najmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheikh","family":"Raisuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2018.02.016_bib0005","doi-asserted-by":"crossref","first-page":"592","DOI":"10.5604\/17322693.1009703","article-title":"Bladder urotoxicity pathophysiology induced by the oxazaphosphorine alkylating agents and its chemoprevention","volume":"66","author":"Dobrek","year":"2012","journal-title":"Postepy Hig Med Dosw"},{"issue":"2","key":"10.1016\/j.pharep.2018.02.016_bib0010","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/bph.12467","article-title":"Role of CXCR2 and TRPV1 in functional, inflammatory and behavioural changes in the rat model of cyclophosphamide\u2010induced haemorrhagic cystitis","volume":"171","author":"Dornelles","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2018.02.016_bib0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-8518-6-6","article-title":"CXCL10 blockade protects mice from cyclophosphamide-induced cystitis","volume":"6","author":"Sakthivel","year":"2008","journal-title":"J Immune Based Ther Vaccines"},{"issue":"1","key":"10.1016\/j.pharep.2018.02.016_bib0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaci.2005.08.057","article-title":"The CC chemokine eotaxin\/CCL11 has a selective profibrogenic effect on human lung fibroblasts","volume":"117","author":"Puxeddu","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pharep.2018.02.016_bib0025","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/bcpt.12627","article-title":"Cyclophosphamide-induced down-regulation of uroplakin II in the mouse urinary bladder epithelium is prevented by S-allyl cysteine","volume":"119","author":"Abdi","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"6","key":"10.1016\/j.pharep.2018.02.016_bib0030","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1309\/AJCP1J0JPJBPSUXF","article-title":"Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants","volume":"142","author":"Li","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.pharep.2018.02.016_bib0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.ki.5002053","article-title":"Uroplakins: new molecular players in the biology of urinary tract malformations","volume":"71","author":"Jenkins","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.pharep.2018.02.016_bib0040","unstructured":"US Food and Drug Administration [2009] Available from https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2002\/20-855_Mesnex_Prntlbl.pdf. 2009 (Accessed 29 July 2017)."},{"issue":"2","key":"10.1016\/j.pharep.2018.02.016_bib0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0970-1591.65380","article-title":"Hemorrhagic cystitis: a challenge to the urologist","volume":"26","author":"Manikandan","year":"2010","journal-title":"Indian J Urol"},{"issue":"9","key":"10.1016\/j.pharep.2018.02.016_bib0050","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3899\/jrheum.150065","article-title":"Incidence of cyclophosphamide-induced urotoxicity and protective effect of mesna in rheumatic diseases","volume":"42","author":"Yilmaz","year":"2015","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.pharep.2018.02.016_bib0055","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1016\/j.fct.2008.08.011","article-title":"Protective effect of S-allylcysteine against cyclophosphamide-induced bladder hemorrhagic cystitis in mice","volume":"46","author":"Bhatia","year":"2008","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"10.1016\/j.pharep.2018.02.016_bib0060","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0022-5347(17)44929-9","article-title":"Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) therapy","volume":"136","author":"Gray","year":"1986","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.pharep.2018.02.016_bib0065","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.pharep.2018.02.016_bib0070","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2013\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"2","key":"10.1016\/j.pharep.2018.02.016_bib0075","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.urology.2009.11.045","article-title":"UPK3A: a promising novel urinary marker for the detection of bladder cancer","volume":"76","author":"Lai","year":"2010","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.pharep.2018.02.016_bib0080","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1349-7006.1998.tb00643.x","article-title":"Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma","volume":"89","author":"Yuasa","year":"1998","journal-title":"Jpn J Cancer Res"},{"issue":"6","key":"10.1016\/j.pharep.2018.02.016_bib0085","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/0960327115597466","article-title":"Urinary uroplakin expression in cyclophosphamide- induced rat cystitis model","volume":"35","author":"Park","year":"2016","journal-title":"Hum Exp Toxicol"},{"issue":"4","key":"10.1016\/j.pharep.2018.02.016_bib0090","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.7314\/APJCP.2015.16.4.1539","article-title":"High expression level of preoperative serum uroplakin III is associated with biologically aggressive bladder cancer","volume":"16","author":"Tsumura","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"10.1016\/j.pharep.2018.02.016_bib0095","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/sj.bjp.0706728","article-title":"Rosmarinic acid as a downstream inhibitor of IKK\u2010\u03b2 in TNF\u2010\u03b1\u2010induced upregulation of CCL11 and CCR3","volume":"148","author":"Lee","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharep.2018.02.016_bib0100","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/pros.22597","article-title":"CCL11 (eotaxin\u20101): a new diagnostic serum marker for prostate cancer","volume":"73","author":"Agarwal","year":"2013","journal-title":"Prostate"},{"issue":"22","key":"10.1016\/j.pharep.2018.02.016_bib0105","doi-asserted-by":"crossref","first-page":"32617","DOI":"10.18632\/oncotarget.8958","article-title":"Expression and prognostic significance of CCL11\/CCR3 in glioblastoma","volume":"7","author":"Tian","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.pharep.2018.02.016_bib0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1152\/physiolgenomics.00117.2001","article-title":"Changes in urinary bladder cytokine mRNA and protein after cyclophosphamide-induced cystitis","volume":"9","author":"Malley","year":"2002","journal-title":"Physiol Genom"},{"key":"10.1016\/j.pharep.2018.02.016_bib0115","first-page":"16","article-title":"The antioxidant mechanisms underlying the aged garlic extract \u2013 and S-allylcysteine-induced protection","author":"Colin-Gonzalez","year":"2012","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.pharep.2018.02.016_bib0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuint.2015.06.011","article-title":"On the antioxidant, neuroprotective and anti-inflammatory properties of S-allylcysteine: an update","volume":"89","author":"Colin-Gonzalez","year":"2015","journal-title":"Neurochem Int"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017305169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017305169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:33Z","timestamp":1752611853000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2018.02.016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1734114017305169"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2018.02.016","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S-allyl cysteine ameliorates cyclophosphamide-induced downregulation of urothelial uroplakin IIIa with a concomitant effect on expression and release of CCL11and TNF-\u03b1 in mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2018.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}